Mean expression of the X-chromosome is associated with neuronal density

Frontiers in Neuroscience

Volumn , Issue NOV, 2012, Pages

  Swingland, James T ^a   Durrenberger, Pascal F ^b   Reynolds, Richard ^b   Dexter, David T ^b   Pombo, Ana ^c   Deprez, Manuel ^d   Roncaroli, Federico ^b   Turkheimer, Federico E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^d UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Chromosome X; Chromowave; Dosage compensation; Neuronal concentration; Wavelets

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; ASTROCYTOSIS; AUTOSOME; BLOOD CELL; CELL DENSITY; CELL TYPE; DEGENERATIVE DISEASE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUNTINGTON CHOREA; MICROARRAY ANALYSIS; MICROGLIA; NERVE CELL; PARKINSON DISEASE; X CHROMOSOME;

EID: 84870868629     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2012.00161     Document Type: Article

References (40)

1. Alter, O., Brown, P. O., and Botstein, D. (2000). Singular value decom position for genome-wide expres sion data processing and model ing. Proc. Natl. Acad. Sci. U.S.A. 97, 10101-10106.
2. Anderson, A. N., Roncaroli, F., Hodges, A., Deprez, M., and Turkheimer, F. E. (2008). Chromosomal profiles of gene expression in Huntington's dis ease. Brain 131, 381-388.
3. Blalock, E. M., Geddes, J. W., Chen, K. C., Porter, N. M., Markesbery, W. R., and Landfield, P. W. (2004). Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl. Acad. Sci. U.S.A. 101, 2173-2178.
4. Bossers, K., Meerhoff, G., Balesar, R., van Dongen, J. W., Kruse, C. G., Swaab, D. F., et al. (2009). Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol. 19, 91-107.
5. Brown, C. J., and Greally, J. M. (2003). A stain upon the silence: genes escaping X inactivation. Trends Genet. 19, 432-438.
6. Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopher-son, K. S., et al. (2008). A transcrip-tome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neu-rosci. 28, 264-278.
7. Chadwick, L. H., and Wade, P.A. (2007). MeCP2 in Rett syndrome: transcriptional repressor or chromatin architectural protein? Curr. Opin. Genet. Dev. 17, 121-125.
8. Clarke, J., Seo, P., and Clarke, B. (2010). Statistical expression deconvolution from mixed tissue samples. Bioinfor-matics 26, 1043-1049.
9. Deng, X., Hiatt, J. B., Nguyen, D. K., Ercan, S., Sturgill, D., Hillier, L. W., et al. (2011). Evidence for compensatory upregulation of expressed X-linked genes in mammals, Caenorhabditis elegans and Drosophila melanogaster. Nat. Genet. 43, 1179-1185.
10. Dunckley, T., Beach, T. G., Ramsey, K. E., Grover, A., Mastroeni, D., Walker, D. G., et al. (2006). Gene expression correlates of neurofibrillary tangles in Alzheimer's disease. Neurobiol. Aging 27, 1359-1371.
11. Durrenberger, P. F., Grünblatt, E., Fernando, F. S., Monoranu, C. M., Evans, J., Riederer, P., et al. (2012). Inflammatory pathways in Parkinson's disease; A BNE microarray study. Parkinsons Dis. 2012, 1-16.
12. Fang, F., Wirdefeldt, K., Jacks, A., Kamel, E, Ye, W., and Chen, H. (2012). CNS Infections, Sepsis and Risk of Parkinson's Disease. International Journal of Epidemiology. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22523201 [accessed May 29,2012].
13. Gómez-Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C.,et al. (1997). Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41, 17-24.
14. Haaxma, C. A., Bloem, B. R., Borm, G. F., Oyen, W J., Leenders, K. L., Eshuis, S., et al. (2007). Gender differences in Parkinson's disease. J. Neurol. Neurosurg. Psychiatr. 78, 819-824.
15. Hedreen, J. C., and Folstein, S. E. (1995). Early loss of neostriatal striosome neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 54,105-120.
16. Hodges, A., Strand, A. D., Aragaki,A. K., Kuhn, A., Sengstag, T., Hughes, G., et al. (2006). Regional and cellular gene expression changes in human Huntington's disease brain. Hum. Mol. Genet. 15, 965-977.
17. Hurst, L. D., Pál, C., and Lercher, M. J. (2004). The evolutionary dynamics of eukaryotic gene order. Nat. Rev. Genet. 5,299-310.
18. Kharchenko, P. V., Xi, R., and Park, P. J. (2011). Evidence for dosage compensation between the X chromosome and autosomes in mammals. Nat. Genet. 43, 1167-1169.
19. Langfelder, P., and Horvath, S. (2008). WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559. doi:10.1186/1471-2105-9-559
20. Laumonnier, F., Cuthbert, P. C., and Grant, S. G. N. (2007). The role of neuronal complexes in human X-linked brain diseases. Am. J. Hum. Genet. 80, 205-220.
21. Libert, C., Dejager, L., and Pinheiro, I. (2010). The X chromosome in immune functions: when a chromosome makes the difference. Nat. Rev. Immunol. 10, 594-604.
22. Lio, P. (2003). Wavelets in bioinformatics and computational biology: state of art and perspectives. Bioinformatics 19, 2-9.
23. Mar, J. C., Matigian, N. A., Mackay-Sim, A., Mellick, G. D., Sue, C. M., Sil-burn, P. A., et al. (2011). Variance of gene expression identifies altered network constraints in neurological disease. PLoS Genet. 7, e1002207. doi:10.1371/journal.pgen.1002207
24. Medeiros, R., Chabrier, M. A., and Laferla, E M. (2012). Elucidating the Triggers, Progression, and Effects of Alzheimer's Disease. Journal of Alzheimer's Disease: JAD. Available at: http://www.ncbi.nlm.nih.gov/ pubmed/22635105 [accessed May 29,2012].
25. Mitchell, A. C., and Mirnics, K. (2012). Gene expression profiling of the brain: pondering facts and fiction. Neurobiol. Dis. 45, 3-7.
26. Moran, L. B., Duke, D. C., Deprez, M., Dexter, D. T., Pearce, R. K. B., and Graeber, M. B. (2006). Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease. Neurogenetics 7, 1-11.
27. Nguyen, D. K., and Disteche, C. M. (2006). Dosage compensation of the active X chromosome in mammals. Nat. Genet. 38, 47-53.
28. Nguyen, D. K., and Disteche, C. M. (2006). High expression of the mammalian X chromosome in brain. Brain Res. 1126, 46-49.
29. Oldham, M. C., Konopka, G., Iwamoto, K., Langfelder, P., Kato, T., Horvath, S., et al. (2008). Functional organization of the transcriptome in human brain. Nat. Neurosci. 11, 1271-1282.
30. Oostra, B. A., and Willemsen, R. (2002). The X chromosome and fragile X mental retardation. Cytogenet. Genome Res. 99, 257-264.
31. Papapetropoulos, S., Ffrench-Mullen, J., McCorquodale, D., Qin, Y., Pablo, J., and Mash, D. C. (2006). Mul-tiregional gene expression profiling identifies MRPS6 as a possible candidate gene for Parkinson's disease. GeneExpr. 13, 205-215.
32. Rock, R. B., Hu, S., Deshpande, A., Munir, S., May, B. J., Baker, C. A., et al. (2005). Transcriptional response of human microglial cells tointerferon-gamma. GenesImmun. 6, 712-719.
33. Saing, T., Dick, M., Nelson, P. T., Kim, R. C., Cribbs, D. H., and Head, E. (2012). Frontal cortex neuropathol-ogy in dementia pugilistica. J. Neu-rotrauma 29, 1054-1070.
34. Scherzer, C. R., Eklund, A. C., Morse, L. J., Liao, Z., Locascio, J. J., Fefer, D., et al. (2007). Molecular markers of early Parkinson's disease based on gene expression in blood. Proc. Natl. Acad. Sci. U.S.A. 104, 955-960.
35. Straub, T., and Becker, P. B. (2007). Dosage compensation: the beginning and end of generalization. Nat. Rev. Genet. 8,47-57.
36. Svyryd, Y., Hernández-Molina, G., Vargas,F., Sánchez-Guerrero, J., Segovia, D. A., and Mutchinick, O. M. (2012). X chromosome monosomy in primary and overlapping autoimmune diseases. Autoimmun. Rev. 11, 301-304.
37. Turkheimer, E E., Roncaroli, F., Hen-nuy, B., Herens, C., Nguyen, M., Martin, D., et al. (2006). Chromosomal patterns of gene expression from microarray data: methodology, validation and clinical relevance in gliomas. BMC Bioinformatics 7, 526. doi:10.1186/1471-2105-7-526
38. Weng, L., Dai, H., Zhan, Y., He, Y., Stepaniants, S. B., and Bassett, D. E. (2006). Rosettaerror model for gene expression analysis. Bioinformatics 22,1111-1121.
39. Zanni, G., and Bertini, E. S. (2011). X-linked disorders with cerebellar dysgenesis. Orphanet. J. Rare Dis. 6, 24.
40. Zheng, B., Liao, Z., Locascio, J. J., Les-niak, K. A., Roderick, S. S., Watt, M. L., et al. (2010). PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease. Sci. Transl. Med. 2, 52ra73.